NZD37.01
1.09%
New Zealand Exchange, Fri, Oct 18 2024
ISIN
NZFAPE0001S2
Symbol
FSPKF
Sector

Fisher & Paykel Healthcare Corporation Target price 2024 - Analyst rating & recommendation

Fisher & Paykel Healthcare Corporation Price Target

Target Price NZD33.59
Price NZD37.01
Deviation
Number of Estimates 15
15 Analysts have issued a price target Fisher & Paykel Healthcare Corporation 2025 . The average Fisher & Paykel Healthcare Corporation target price is NZD33.59. This is lower than the current stock price. The highest price target is , the lowest is .
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Fisher & Paykel Healthcare Corporation stock has an average upside potential 2025 of .

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '24 2025
Estimates

15 Analysts have issued a sales forecast Fisher & Paykel Healthcare Corporation 2025 . The average Fisher & Paykel Healthcare Corporation sales estimate is

NZD2.0b
Unlock
. This is
13.49% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
NZD2.0b 15.51%
Unlock
, the lowest is
NZD1.9b 10.06%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026
NZD2.2b 12.26%
Unlock
2027
NZD2.5b 12.00%
Unlock
2028
NZD2.7b 9.31%
Unlock

15 Analysts have issued an Fisher & Paykel Healthcare Corporation EBITDA forecast 2025. The average Fisher & Paykel Healthcare Corporation EBITDA estimate is

NZD605m
Unlock
. This is
25.34% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
NZD636m 31.68%
Unlock
, the lowest is
NZD548m 13.54%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026
NZD710m 17.28%
Unlock
2027
NZD833m 17.35%
Unlock
2028
NZD931m 11.80%
Unlock

EBITDA Margin

2026
31.70% 4.48%
Unlock
2027
33.21% 4.76%
Unlock
2028
33.97% 2.29%
Unlock

10 Fisher & Paykel Healthcare Corporation Analysts have issued a net profit forecast 2025. The average Fisher & Paykel Healthcare Corporation net profit estimate is

NZD361m
Unlock
. This is
168.73% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
NZD373m 178.26%
Unlock
, the lowest is
NZD334m 149.13%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026
NZD428m 18.59%
Unlock
2027
NZD510m 19.13%
Unlock
2028
NZD583m 14.47%
Unlock

Net Margin

2026
19.09% 5.59%
Unlock
2027
20.31% 6.39%
Unlock
2028
21.27% 4.73%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '24 2025
Estimates
P/E 59.88
EV/Sales 10.93

10 Analysts have issued a Fisher & Paykel Healthcare Corporation forecast for earnings per share. The average Fisher & Paykel Healthcare Corporation <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

NZD0.62
Unlock
. This is
169.57% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
NZD0.64 178.26%
Unlock
, the lowest is
NZD0.57 147.83%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026
NZD0.73 17.74%
Unlock
2027
NZD0.87 19.18%
Unlock
2028
NZD1.00 14.94%
Unlock

P/E ratio

Current
2026
50.49 15.68%
Unlock
2027
42.39 16.04%
Unlock
2028
37.03 12.64%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today